Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Endologix, Inc. (NASDAQ: ELGX).

Full DD Report for ELGX

You must become a subscriber to view this report.


Recent News from (NASDAQ: ELGX)

Analysis: Positioning to Benefit within G-III Apparel Group, LTD, Diebold Nixdorf, Endologix, MACOM Technology Solutions, Halyard Health, and REV Group - Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, May 15, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of G-III Apparel Group, LTD. (NASDAQ:GIII), Diebold Nixdorf, Incorporated (NY...
Source: GlobeNewswire
Date: May, 15 2018 08:25
Ad Com June 12 for Cardinal's InCraft stent; shares ahead 6%
The FDA's Medical Devices Advisory Committee's Circulatory Systems Devices Panel will meet on Tuesday, June 12, to discuss the marketing application from Cardinal Health's ( CAH +5.6% ) Cordis unit seeking approval for its InCraft AAA Stent Graft System for the treatment of infrarenal ab...
Source: SeekingAlpha
Date: May, 10 2018 11:33
Endologix's (ELGX) CEO John Onopchenko on Q1 2018 Results - Earnings Call Transcript
Endologix Inc (ELGX) Q1 2018 Earnings Conference Call May 2, 2018 4:30 PM ET Executives Dan Lemaitre - Chairman of the Board John Onopchenko - Chief Executive Officer Vaseem Mahboob - Chief Financial Officer Matthew Thompson - Chief Medical Officer Analysts Matthew Henrik...
Source: SeekingAlpha
Date: May, 04 2018 07:16
Endologix Inc 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by Endologix Inc in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: May, 03 2018 13:20
Endologix misses by $0.07, beats on revenue
Endologix (NASDAQ: ELGX ): Q1 EPS of -$0.24 misses by $0.07 . More news on: Endologix Inc, Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: May, 02 2018 16:39
Endologix Appoints John Onopchenko as Chief Executive Officer
Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it has appointed John Onopchenko as the Company’s Chief Executive Officer, effective immediately. Dan Lemaitre, Chairman of the Board of Directors of Endolo...
Source: Business Wire
Date: May, 02 2018 16:15
Endologix Reports First Quarter 2018 Financial Results
Endologix, Inc. (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the first quarter ended March 31, 2018. “Our top-line performance during the first quarter reflects slightly better-than-expected growth in...
Source: Business Wire
Date: May, 02 2018 16:14
Endovascular Aneurysm Sealing (EVAS) with Nellix System Associated with Higher Survival than Traditional Endovascular Aneurysm Repair (EVAR) in New Study
Results Presented Today in Late-Breaking Aortic Trials Session at Charing Cross International Symposium Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced the results of a study, which was presented by Marc Schermerh...
Source: Business Wire
Date: April, 25 2018 10:00
Endologix, Inc. to Announce First Quarter 2018 Financial Results on May 2, 2018
Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will report financial results for the first quarter of fiscal year 2018 after the market close on Wednesday, May 2, 2018. The Company’s management will h...
Source: Business Wire
Date: April, 03 2018 16:01
After Hours Gainers / Losers (3/19/2018)
Top gainers: ARNA +24.6% . ELGX +8.1% . HLIT +6.4% . AMTX +6.2% . MRNS +6.1% . More news on: Arena Pharmaceuticals, Inc., Endologix Inc, Harmonic Inc., Stocks on the move, , News on ETFs, Read more ...
Source: SeekingAlpha
Date: March, 19 2018 17:41

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-175.064.955.154.86394,485
2017-02-036.876.926.966.75528,361
2017-02-026.926.857.0356.831,515,260
2017-02-016.907.017.146.762,005,396
2017-01-316.506.866.946.371,945,503

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-15140,455332,56042.2345Short
2018-08-14428,500659,95464.9288Short
2018-08-13330,321450,39973.3396Short
2018-08-101,227,1531,663,30773.7779Short
2018-08-0958,440229,51025.4629Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ELGX.


About Endologix, Inc. (NASDAQ: ELGX)

Logo for Endologix, Inc. (NASDAQ: ELGX)

Not available

 

Contact Information

 

 

Current Management

  • Jeffrey H. Thiel / President, CEO
  • Robert J. Krist / CFO

Current Share Structure

  • Market Cap: $407,741,709 - 05/15/2018
  • Issue and Outstanding: 83,725,197 - 03/12/2018

 


Recent Filings from (NASDAQ: ELGX)

Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 17 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Information for Proxy Statement under Rule 14a-101
Filing Type: DEFR14AFiling Source: edgar
Filing Date: April, 30 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: April, 20 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 17 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 13 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: March, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 21 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018

 

 


Daily Technical Chart for (NASDAQ: ELGX)

Daily Technical Chart for (NASDAQ: ELGX)


Stay tuned for daily updates and more on (NASDAQ: ELGX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ELGX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ELGX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of ELGX and does not buy, sell, or trade any shares of ELGX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/